Form D filings with the SEC list Robert Rosen as an Executive Officer of Abingworth Clinical Co-Development Fund 3. See sector focus and contact routes.
Form D filings with the SEC list Robert Rosen as an Executive Officer of Abingworth Clinical Co-Development Fund 3. One Form D filing is on record, for the offering Abingworth Clinical Co-Development Fund 3 LP. The issuer address on file for this offering is Washington. The SEC industry group for this offering is Pooled Investment Fund.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Washington.
SEC Form D filings name Robert Rosen as a related person of one fund (2025). Each entry links to the original filing on sec.gov.
Form D filings identify related persons of the issuing fund. Being named on a filing does not by itself evidence an investment in any company.
Investors like Robert Rosen · Full investor directory · Investor access · Company funding database